Trials / Sponsors / Shandong Public Health Clinical Center
Shandong Public Health Clinical Center
Other Government · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Sta Carcinoma, Non-Small-Cell Lung | Phase 2 | 2025-05-01 |
| Unknown | IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cance Advanced Primary Liver Cancer | EARLY_Phase 1 | 2022-06-30 |